Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Unknown × OKN 007 × Clear all

Phase

Status

Active not recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 49 fludarabine 37 Injections 32 Gemcitabine 24 Paclitaxel 23 Cisplatin 21 pembrolizumab 19 toripalimab 18 Radiotherapy 18 Carboplatin 17 Capecitabine 16 Fluorouracil 13 Oxaliplatin 12 Nivolumab 12 Docetaxel 12 camrelizumab 11 apatinib 11 Temozolomide 11 Cetuximab 10 Immunotherapy, Adoptive 9 Drug Therapy 9 Bevacizumab 9 Irinotecan 8 Etoposide 8 sintilimab 7 Radiosurgery 7 Peripheral Blood Stem Cell Transplantation 7 Ipilimumab 7 Indium 7 Filgrastim 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01672463 2023-03-29

OKN-007

Oblato, Inc.

Phase 1 Unknown

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡